Cargando…
Lower sertraline plasma concentration in patients co‐medicated with clozapine—Implications for pharmacological augmentation strategies in schizophrenia
Augmentation of antipsychotic treatment with antidepressants represents a common and beneficial treatment strategy in patients suffering from schizophrenia. Combining clozapine and the selective serotonin reuptake inhibitor (SSRI) sertraline represents a clinically important strategy in patients wit...
Autores principales: | Gaebler, Arnim Johannes, Haen, Ekkehard, Omar, Nagia Ben, Endres, Katharina, Hiemke, Christoph, Schoretsanitis, Georgios, Paulzen, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950877/ https://www.ncbi.nlm.nih.gov/pubmed/36825450 http://dx.doi.org/10.1002/prp2.1065 |
Ejemplares similares
-
Monitoring sertraline and clozapine levels
por: Rodriguez Campos, A., et al.
Publicado: (2022) -
Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis
por: Kuzo, Nazar, et al.
Publicado: (2022) -
PS212. Effects of Proton Pump Inhibitors (PPI) on the Serum Concentrations of Venlafaxine
por: Paulzen, Michael, et al.
Publicado: (2016) -
Plasma Risperidone-related Measures in Children and Adolescents with Oppositional Defiant/Conduct Disorders
por: Piacentino, Daria, et al.
Publicado: (2020) -
Therapeutic Reference Range for Aripiprazole in Schizophrenia Revised: a Systematic Review and Metaanalysis
por: Hart, Xenia M., et al.
Publicado: (2022)